Colossal Biosciences is a pioneering company in the field of de-extinction, focusing on avian cellular science and biodiversity conservation. The company is advancing efforts to revive extinct species, such as the dodo, through breakthroughs in gene editing and primordial germ cell culture. By developing innovative genomic resources and establishing breeding colonies, Colossal aims to facilitate conservation and rewilding initiatives, while also expanding the possibilities for genetic rescue of endangered bird species.
Leadership & Board
Key Executives
Co-Founder and CEOBen Lamm
Co-Founder & Chief Business OfficerPeter Phillips
Co-Founder + COOKent Wakeford
VP of StrategyAlexander Titus
Current Number of Employees264
Current LinkedIn Followers56,685
Latest Estimated Valuation
Estimated Valuation$10B
Estimated Valuation$10B
Total Amount Raised$120M
Total Amount Raised$120M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$120M
Latest Funding Amount$120M
Latest Funding RoundSeries C
Latest Funding RoundSeries C
Post-Money Valuation$10B
Post-Money Valuation$10B
Employee Trend
Colossal Biosciences had 264 employees as of September 14, 2026. The number of employees decreased by 4 (1.49%) week-over-week.
264Latest Employee Count
4(-1.49%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Colossal Biosciences had 56,685 followers as of September 14, 2026. The number of followers increased by 208 (0.37%) week-over-week.
56,685Latest Followers Count
208(0.37%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.